about
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in AdultsPrimary retinal cultures as a tool for modeling diabetic retinopathy: an overviewAngiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathyBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeOxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyComprehensive analysis of maillard protein modifications in human lenses: effect of age and cataractMethylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction.Lipotoxicity disrupts incretin-regulated human β cell connectivityDyslipidemia and diabetic retinopathy.Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis.Optical control of insulin release using a photoswitchable sulfonylureaRetinal proteins associated with redox regulation and protein folding play central roles in response to high glucose conditions.Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?Endoplasmic reticulum stress-related factors protect against diabetic retinopathyRole of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema.Continuous Glucose Monitoring Systems: A Review.Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study.Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiariesSoluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.Role of the retinal vascular endothelial cell in ocular diseaseAdequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians.Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy.Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.AGEs, RAGE, and diabetic retinopathy.Lipids and diabetic retinopathy.Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs.Diabetic macular edema: current and emerging therapies.Beta cell connectivity in pancreatic islets: a type 2 diabetes target?Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells.AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently.High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy.Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.Polymorphism 2184A/G in the AGER gene is not associated with diabetic retinopathy in Han Chinese patients with type 2 diabetesAdvanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy.Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.
P2860
Q26765813-1E8E5872-E912-4F07-B8D0-7B0D10545E29Q27008921-3E0E19DF-CA67-473A-B657-C0B05F979EFBQ28262797-89A02EC2-C894-47AB-8289-2648D3C5E9B9Q28288148-1D56E826-387C-45C4-AE43-A8753AFD065AQ29248994-973D2AC0-06DE-4AA8-AE94-E73596B2A902Q30316666-6AA349CB-44F6-4726-A788-E0A0754E15CEQ30389325-67E4AC58-7EAD-4F47-8C55-5CA2409E6377Q30634760-4B37728C-AF91-40F3-A1AA-163887A3E036Q33776171-573C2186-F083-4BD7-B629-1FD5854D4299Q34216036-E44C0A1E-E38C-4AAB-9A75-DEAA82AE0761Q34397447-3FB86190-64B1-4A19-AB88-6956C57713C8Q35535076-D66DF218-275A-4469-AD97-D018A4A109B8Q35591570-A33C25D7-BC31-4172-A010-E41EAB67A907Q35607313-4E9F3D78-6F09-4592-A5AB-A9E49B214E69Q35896615-A7D2793B-BECF-4A5F-BCB1-571C10F4199BQ36318318-E338B16A-0923-4A94-8ABB-D4C9275AE772Q36335124-7B6783F5-3957-412C-B216-C0DD9A3AE3BCQ36574142-6E14B001-38D5-4156-9D3F-18D1DB93CA7FQ36753936-25C1E241-3A44-4298-A3CF-063DF4920654Q36791356-1EF1560B-7212-4EBB-8280-2F4586DD339FQ36820462-99AFED79-504A-4E02-A83D-773514F40787Q36919959-344FBDB9-52FA-44E0-A954-3F6D3BD9EB29Q37228679-CF0060EB-6943-4EAC-9618-4D63C8F6A1FBQ37241389-478480D9-37CA-4C82-94C0-902B21512751Q37251091-8A0B438B-A6CF-40DE-8C3B-62F19D4787CEQ37729999-52D2CA2C-EF7C-4776-A8A8-013F9FF4844CQ37876790-D23339D3-83EA-456C-958E-108C05E1A42BQ37961883-8468D1B5-DB2A-4FFA-8E7A-F8A72C372039Q37979691-E9E4900F-C921-49E3-985A-04C60BD97581Q37985854-5B63A05A-90D2-4675-A197-898D90D95789Q38260861-3ABC38BF-063F-4311-B397-AAAAEA2AEB13Q38698313-54FF6DB8-1F2E-4C47-A2D7-6CA950C538F4Q38858414-8C4FA1B8-E130-46C4-AD07-F16B55644C1FQ38909591-C02A9E61-76AB-47C8-B177-2194CA7E0A89Q39262816-FC5BA692-A869-46CC-83A6-261DCBD2E685Q39727356-5BB2E7F0-6803-473C-87FC-F7B9761C7967Q40789140-A8A28FB3-3EFE-4B80-9C50-4A2F7D0455A0Q42340230-743282EE-8EF6-4CC6-B42A-F18BB7EBF3A7Q47121856-8F18B999-A27C-41DB-8596-A14F042BC6A5Q50049076-93F51726-ED04-4C0E-B2AD-64DC7985B095
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AGEs and diabetic retinopathy.
@en
AGEs and diabetic retinopathy.
@nl
type
label
AGEs and diabetic retinopathy.
@en
AGEs and diabetic retinopathy.
@nl
prefLabel
AGEs and diabetic retinopathy.
@en
AGEs and diabetic retinopathy.
@nl
P356
P1476
AGEs and diabetic retinopathy
@en
P2093
Alan W Stitt
P304
P356
10.1167/IOVS.10-5881
P407
P50
P577
2010-10-01T00:00:00Z